FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a 1,3,4-oxadiazole derivative represented by the chemical formula I, or to a pharmaceutically acceptable salt thereof, where in the chemical formula I Z1-Z4 each independently represents N, CH or CX, where Z1-Z4 is not may be three or more N's at the same time; L, L1 or L2 are each independently -(C0-C2alkylene)-; R1 represents -CX2H or -CX3; R2 represents C6 aryl, wherein at least one -H of C6 aryl can each be independently substituted with -X, -OH, -(C1-C4alkyl) or -O(C1-C4alkyl); R represents or; Ra-Rd are each independently -H or -(C1-C4alkyl); R´ and R˝ are each independently -H, -(C1-C4alkyl), -(C3-C7cycloalkyl), -(C2-C6heterocycloalkyl) containing one O atom or one S atom in the ring, -(C1-C4alkyl)-(C3-C7cycloalkyl), -(C1-C4alkyl)-(C2-C6heterocycloalkyl), containing one O atom in the ring, -C (=O)-(C1-C4alkyl), -C(=O)-(C3-C7cycloalkyl), -C(=O)-O(C1-C4alkyl) or -S( =O)2 -(C1-C4alkyl), wherein at least one -H of -(C1-C4alkyl) or -C(=O)-(C1-C4alkyl) may be is substituted by -X, -OH, -N(CH3)2 or -O(C1-C4alkyl) and at least one -H in the ring of -(C3-C7cycloalkyl) may be substituted by - X, -OH or -(C1-C4alkyl); m or n are each independently 1, 2 or 3; and X represents either F, Cl, Br or I. The invention also relates to a pharmaceutical composition having inhibitory activity against histone deacetylase 6 (HDAC6), based on the specified derivative of Chemical formula I.
EFFECT: obtaining new compounds and a pharmaceutical composition based on them which may have medical applications to prevent or treat HDAC6-mediated diseases, including cancer, inflammatory diseases, autoimmune diseases, neurological or neurodegenerative diseases.
9 cl, 2 tbl, 128 ex
Title | Year | Author | Number |
---|---|---|---|
1,3,4-OXADIAZOLE DERIVATIVES AS HISTONE DEACETYLASE 6 INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 2021 |
|
RU2822180C1 |
1,3,4-OXADIAZOLE DERIVATIVES AS HISTONE DEACETYLASE 6 INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 2021 |
|
RU2822624C1 |
1,3,4-OXADISOLAMIDE DERIVATIVE COMPOUND AS HISTONE DEACETYLASE 6 INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 2016 |
|
RU2700696C2 |
1,3,4-OXADIAZOLE HOMOPHTHALIMIDE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | 2020 |
|
RU2793331C1 |
NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | 2021 |
|
RU2814288C1 |
USE OF 1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS | 2017 |
|
RU2759380C2 |
1,3,4-OXADIAZOLE DERIVATIVES AS HISTONE DEACETYLASE 6 INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | 2019 |
|
RU2763936C1 |
1,3,4-OXADIAZOLE SULPHAMIDE DERIVATIVES AS HISTONE DEACETYLASE 6 INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | 2016 |
|
RU2695227C1 |
1,3,4-OXADIAZOLE SULPHONAMIDE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS 6 AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 2016 |
|
RU2697665C1 |
INDOLIN-2-ONE OR PYRROLO-PYRIDIN/PYRIMIDIN-2-ONE DERIVATIVES | 2014 |
|
RU2666532C2 |
Authors
Dates
2023-12-21—Published
2021-04-12—Filed